Quarterly report pursuant to Section 13 or 15(d)

CONDENSED STATEMENTS OF OPERATIONS

v3.22.1
CONDENSED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Total revenues $ 16,735 $ 81,018
Costs and expenses:    
Cost of product sales 121 316
Research and development 15,474 16,826
Selling, general and administrative 27,401 22,121
Total costs and expenses 42,996 39,263
Income (loss) from operations (26,261) 41,755
Interest income 21 1
Interest expense (1,205) (485)
Income (loss) before income taxes (27,445) 41,271
Provision for income taxes 0 1,771
Net income (loss) $ (27,445) $ 39,500
Net income (loss) per share, basic and diluted    
Basic (in dollars per share) $ (0.16) $ 0.23
Diluted (in dollars per share) $ (0.16) $ 0.22
Weighted average shares used in computing net income (loss) per share, basic and diluted    
Basic (in shares) 171,774 169,800
Diluted (in shares) 171,774 176,069
Product sales, net    
Total revenues $ 16,197 $ 12,376
Revenues from collaborations    
Total revenues $ 538 65,642
Government contract    
Total revenues   $ 3,000